{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:27:13Z","timestamp":1791073633942,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2009,1,27]],"date-time":"2009-01-27T00:00:00Z","timestamp":1233014400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1007\/s00198-009-0839-8","type":"journal-article","created":{"date-parts":[[2009,1,26]],"date-time":"2009-01-26T14:43:00Z","timestamp":1232980980000},"page":"1603-1611","source":"Crossref","is-referenced-by-count":82,"title":["Milk ribonuclease-enriched lactoferrin induces positive effects on bone turnover markers in postmenopausal women"],"prefix":"10.1007","volume":"20","author":[{"given":"S.","family":"Bharadwaj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. G. T.","family":"Naidu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. V.","family":"Betageri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. V.","family":"Prasadarao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. S.","family":"Naidu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,1,27]]},"reference":[{"key":"839_CR1","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/jbmr.5650070902","volume":"7","author":"U Melton","year":"1992","unstructured":"Melton U, Chrischilles EA, Cooper C et al (1992) How many women have osteoporosis? J Bone Miner Res 7:1005\u20131010","journal-title":"J Bone Miner Res"},{"key":"839_CR2","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1359\/jbmr.1998.13.12.1915","volume":"13","author":"LJ Melton 3rd","year":"1998","unstructured":"Melton LJ 3rd, Atkinson EJ, O\u2019Connor MK et al (1998) Bone density and fracture risk in men. J Bone Miner Res 13:1915","journal-title":"J Bone Miner Res"},{"key":"839_CR3","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/humupd\/dmi028","volume":"11","author":"JA Collins","year":"2005","unstructured":"Collins JA, Blake JM, Crosignani PG (2005) Breast cancer risk with postmenopausal hormonal treatment. Hum Reprod Update 11:545\u2013560","journal-title":"Hum Reprod Update"},{"key":"839_CR4","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.1056\/NEJMp038108","volume":"349","author":"DM Herrington","year":"2003","unstructured":"Herrington DM, Howard TD (2003) Hormone therapy and heart disease: from presumed benefit to potential harm. N Engl J Med 349:5519\u20135521","journal-title":"N Engl J Med"},{"key":"839_CR5","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1517\/14740338.2.4.421","volume":"2","author":"R Makins","year":"2003","unstructured":"Makins R, Ballinger A (2003) Gastrointestinal side effects of drugs. Expert Opin Drug Safety 2:421\u2013429","journal-title":"Expert Opin Drug Safety"},{"key":"839_CR6","first-page":"1","volume":"11","author":"H Kawakami","year":"2005","unstructured":"Kawakami H (2005) Biological significance of milk basic protein (MBP) for bone health. Food Sci Technol 11:1\u20138","journal-title":"Food Sci Technol"},{"key":"839_CR7","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1271\/bbb.65.913","volume":"65","author":"S Aoe","year":"2001","unstructured":"Aoe S, Toba Y, Yamamura J et al (2001) Controlled trial of the effects of milk basic protein (MBP) supplementation on bone metabolism in healthy adult women. Biosci Biotechnol Biochem 65:913\u2013918","journal-title":"Biosci Biotechnol Biochem"},{"key":"839_CR8","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1271\/bbb.66.702","volume":"66","author":"J Yamamura","year":"2002","unstructured":"Yamamura J, Aoe S, Toba Y et al (2002) Milk basic protein (MBP) increases radial bone mineral density in healthy adult women. Biosci Biotechnol Biochem 66:702\u2013704","journal-title":"Biosci Biotechnol Biochem"},{"key":"839_CR9","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.bone.2007.10.012","volume":"42","author":"Y Morita","year":"2008","unstructured":"Morita Y, Matsuyama H, Serizawa A et al (2008) Identification of angiogenin as the osteoclastic bone resorption-inhibitory factor in bovine milk. Bone 42:380\u2013387","journal-title":"Bone"},{"key":"839_CR10","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1097\/00003086-199810001-00010","volume":"355S","author":"J Glowacki","year":"1998","unstructured":"Glowacki J (1998) Angiogenesis in fracture repair. Clin Orthop 355S:S82\u2013S89","journal-title":"Clin Orthop"},{"key":"839_CR11","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S1359-6446(03)02866-6","volume":"8","author":"RAD Carano","year":"2003","unstructured":"Carano RAD, Filvaroff E (2003) Angiogenesis and bone repair. Drug Discov Today 8:980\u2013989","journal-title":"Drug Discov Today"},{"key":"839_CR12","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1210\/en.2003-1307","volume":"145","author":"J Cornish","year":"2004","unstructured":"Cornish J, Callon KE, Naot D et al (2004) Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vitro. Endocrinology 145:4366\u20134374","journal-title":"Endocrinology"},{"key":"839_CR13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3121\/cmr.3.2.93","volume":"3","author":"D Naot","year":"2005","unstructured":"Naot D (2005) Lactoferrin: a novel bone growth factor. Clin Med Res 3:93\u2013101","journal-title":"Clin Med Res"},{"key":"839_CR14","unstructured":"Naidu AS (2008) Angiogenin complexes (ANGex) and uses thereof. US Patent Application No. 20080255340"},{"key":"839_CR15","unstructured":"Naidu AS (2008) Immobilized angiogenin mixtures and uses thereof. US Patent Application No. 20080254018"},{"issue":"11","key":"839_CR16","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1093\/clinchem\/41.11.1560","volume":"41","author":"B Gomez Jr","year":"1995","unstructured":"Gomez B Jr, Ardakani S, Ju J et al (1995) Monoclonal antibody assay for measuring bone-specific alkaline phosphatase activity in serum. Clin Chem 41(11):1560\u20131566","journal-title":"Clin Chem"},{"key":"839_CR17","first-page":"470","volume":"102","author":"PD Delmas","year":"1983","unstructured":"Delmas PD, Stenner D, Wahner HW et al (1983) Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone gla-protein. J Lab Clin Med 102:470\u2013476","journal-title":"J Lab Clin Med"},{"key":"839_CR18","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1093\/clinchem\/43.11.2058","volume":"43","author":"JD Clemens","year":"1997","unstructured":"Clemens JD et al (1997) Evidence that serum NTx (collagen type I N-telopeptides) can act as immunochemical marker of bone resorption. Clin Chem 43:2058\u20132063","journal-title":"Clin Chem"},{"key":"839_CR19","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/jbmr.5650060615","volume":"6","author":"PD Delmas","year":"1991","unstructured":"Delmas PD, Schlemmer A, Gineyts E et al (1991) Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured in iliac crest biopsy in patients with vertebral osteoporosis. J Bone Miner Res 6:639\u2013644","journal-title":"J Bone Miner Res"},{"key":"839_CR20","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0009-8981(73)90466-X","volume":"43","author":"D Heinegard","year":"1973","unstructured":"Heinegard D, Tiderstrom G (1973) Determination of serum creatinine by a direct colorimetric method. Clin Chim Acta 43:305","journal-title":"Clin Chim Acta"},{"key":"839_CR21","first-page":"475","volume-title":"Biostatistical analysis","author":"JH Zar","year":"1999","unstructured":"Zar JH (1999) Biostatistical analysis, 4th edn. Prentice Hall, NJ, p 475","edition":"4"},{"key":"839_CR22","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1359\/jbmr.2000.15.3.594","volume":"15","author":"R Eastell","year":"2000","unstructured":"Eastell R, Mallinak N, Weiss S et al (2000) Biological variability of serum and urinary N-telopeptides of type I collagen in postmenopausal women. J Bone Miner Res 15:594\u2013598","journal-title":"J Bone Miner Res"},{"key":"839_CR23","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S8756-3282(98)00126-4","volume":"23","author":"JK Scariano","year":"1998","unstructured":"Scariano JK, Glew RH, Bou-Serhal CE et al (1998) Serum levels of cross-linked N-telopeptides and aminoterminal propeptides of type I collagen indicate low bone mineral density in elderly women. Bone 23:471\u2013477","journal-title":"Bone"},{"key":"839_CR24","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s002239900497","volume":"63","author":"BJ Gertz","year":"1998","unstructured":"Gertz BJ, Clemens JD, Holland SD et al (1998) Application of a new serum assay for type i collagen cross-linked N-telopeptides: assessment of diurnal changes in bone turnover with and without alendronate treatment. Calcif Tissue Int 63:102\u2013106","journal-title":"Calcif Tissue Int"},{"key":"839_CR25","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1093\/clinchem\/43.11.2058","volume":"43","author":"JD Clemens","year":"1997","unstructured":"Clemens JD, Herrick MV, Singer FR et al (1997) Evidence that serum NTx (collagen-type I N-telopeptides) can act as an immunochemical marker of bone resorption. Clin Chem 43:2058\u20132063","journal-title":"Clin Chem"},{"key":"839_CR26","first-page":"179","volume":"84","author":"KM Prestwood","year":"1999","unstructured":"Prestwood KM, Thompson DL, Kenny AM et al (1999) Low dose estrogen and calcium have an additive effect on bone resorption in older women. J Clin Endocrinol Metab 84:179\u2013183","journal-title":"J Clin Endocrinol Metab"},{"key":"839_CR27","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00223-003-0114-5","volume":"74","author":"HN Rosen","year":"2004","unstructured":"Rosen HN, Parker RA, Greenspan SL et al (2004) Evaluation of ability of biochemical markers of bone turnover to predict a response to increased doses of HRT. Calcif Tissue Int 74:415\u2013423","journal-title":"Calcif Tissue Int"},{"key":"839_CR28","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1359\/JBMR.041125","volume":"20","author":"FN Ton","year":"2005","unstructured":"Ton FN, Gunawardene SC, Lee H et al (2005) Effects of low-dose prednisone on bone metabolism. J Bone Miner Res 20:464\u2013470","journal-title":"J Bone Miner Res"},{"key":"839_CR29","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1359\/jbmr.1998.13.9.1431","volume":"13","author":"SL Greenspan","year":"1998","unstructured":"Greenspan SL, Parker R, Ferguson L et al (1998) Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial. J Bone Mineral Res 13:1431\u20131438","journal-title":"J Bone Mineral Res"},{"key":"839_CR30","first-page":"1693","volume":"79","author":"P Garnero","year":"1994","unstructured":"Garnero P, Shih WJ, Gineyts E et al (1994) Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab 79:1693\u20131700","journal-title":"J Clin Endocrinol Metab"},{"key":"839_CR31","doi-asserted-by":"crossref","first-page":"5212","DOI":"10.1210\/jc.2005-0573","volume":"90","author":"IR Reid","year":"2005","unstructured":"Reid IR, Lucas J, Wattie D et al (2005) Effects of a \u03b2-blocker on bone turnover in normal postmenopausal women: a randomized controlled trial. J Clin Endocrinol Metab 90:5212\u20135216","journal-title":"J Clin Endocrinol Metab"},{"key":"839_CR32","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1359\/JBMR.050105","volume":"20","author":"P Chen","year":"2005","unstructured":"Chen P, Satterwhite JH, Licata AA et al (2005) Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis. J Bone Miner Res 20:962\u2013970","journal-title":"J Bone Miner Res"},{"key":"839_CR33","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1139\/o01-228","volume":"80","author":"YA Suzuki","year":"2002","unstructured":"Suzuki YA, Lonnerdal B (2002) Characterization of mammalian receptors for lactoferrin. Biochem Cell Biol 80:75\u201380","journal-title":"Biochem Cell Biol"},{"key":"839_CR34","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1210\/me.2003-0456","volume":"18","author":"A Grey","year":"2004","unstructured":"Grey A, Banovic T, Zhu Q et al (2004) The low-density lipoprotein receptor-related protein 1 is a mitogenic receptor for lactoferrin in osteoblastic cells. Mol Endocrinol 18:2268\u20132278","journal-title":"Mol Endocrinol"},{"key":"839_CR35","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1023\/A:1010450023203","volume":"35","author":"OP Shestenko","year":"2001","unstructured":"Shestenko OP, Nikonov SD, Mertvetsov NP (2001) Angiogenin and its functions in angiogenesis. Mol Biol 35:294\u2013314","journal-title":"Mol Biol"},{"key":"839_CR36","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0002-9343(99)80134-X","volume":"99","author":"CH Chesnut III","year":"1995","unstructured":"Chesnut CH III, McClung MR, Ensrud KE et al (1995) Alendronate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass and bone remodeling. Am J Med 99:144\u2013152","journal-title":"Am J Med"},{"key":"839_CR37","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","volume":"282","author":"B Ettinger","year":"1999","unstructured":"Ettinger B, Black DM, Mitlak BH et al (1999) Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. JAMA 282:637\u2013645","journal-title":"JAMA"},{"key":"839_CR38","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1359\/jbmr.1998.13.11.1747","volume":"13","author":"EG Lufkin","year":"1998","unstructured":"Lufkin EG, Whitaker MD, Nickelsen T et al (1998) Treatment of established postmenopausal osteoporosis with raloxifene: a randomized trial. J Bone Miner Res 13:1747\u20131754","journal-title":"J Bone Miner Res"},{"key":"839_CR39","first-page":"2060","volume":"87","author":"PJ Meunier","year":"2002","unstructured":"Meunier PJ, Slosman DO, Delmas PD et al (2002) Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis\u2014a 2-year randomized placebo controlled trial. J Clin Endocrinol Metab 87:2060\u20132066","journal-title":"J Clin Endocrinol Metab"},{"key":"839_CR40","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1359\/JBMR.040716","volume":"19","author":"SA Jamal","year":"2004","unstructured":"Jamal SA, Cummings SR, Hawker GA (2004) Isosorbide mononitrate increases bone formation and decreases bone resorption in postmenopausal women: a randomized trial. J Bone Miner Res 19:1512\u20131517","journal-title":"J Bone Miner Res"},{"key":"839_CR41","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11926-006-0028-0","volume":"8","author":"F Cosman","year":"2006","unstructured":"Cosman F (2006) Anabolic therapy for osteoporosis: parathyroid hormone. Curr Rheumat Rep 8:63\u201369","journal-title":"Curr Rheumat Rep"},{"key":"839_CR42","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2165\/00002018-199819010-00003","volume":"19","author":"S Asirvatham","year":"1998","unstructured":"Asirvatham S, Sebastian C, Thadani U (1998) Choosing the most appropriate treatment for stable angina. Safety considerations. Drug Saf 19:23\u201344","journal-title":"Drug Saf"},{"key":"839_CR43","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/01926230252929882","volume":"30","author":"JL Vahle","year":"2002","unstructured":"Vahle JL, Sato M, Long GG et al (2002) Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1\u201334) for two years and relevance to human safety. Toxicol Pathol 30:312\u2013321","journal-title":"Toxicol Pathol"},{"key":"839_CR44","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1210\/er.2004-0006","volume":"26","author":"AB Hodsman","year":"2005","unstructured":"Hodsman AB, Bauer DC, Dempster DW et al (2005) Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocr Rev 26:688\u2013703","journal-title":"Endocr Rev"},{"key":"839_CR45","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1210\/jcem.87.4.8415","volume":"87","author":"MC Hochberg","year":"2002","unstructured":"Hochberg MC, Greenspan S, Wasnich RD et al (2002) Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents. J Clin Endocrinol Metab 87:1586\u20131592","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-009-0839-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-009-0839-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-009-0839-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T02:07:11Z","timestamp":1589508431000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-009-0839-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,27]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["839"],"URL":"https:\/\/doi.org\/10.1007\/s00198-009-0839-8","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,27]]}}}